Spirea
Latest round
- Seed
Last raised
- Jul 2020
Total raised
- Undisclosed
Investors
- 2
About Spirea
, operates as a biotechnology company that develops antibody-drug conjugates for cancer treatments. The company offers therapeutic solutions used for cancer treatment along with real-time data analysis solutions to optimize the efficacy and safety of ADC therapies. They collaborate with renowned hospitals and medical institutions to conduct clinical trials and validate their innovative ADC platform. The company’s technology specifically targets and destroys cancer cells, minimizing side effects and improving treatment outcomes.
Who invested in Spirea
2 investors across 1 round
See all investors in Spirea
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 13, 2020
Amount
Undisclosed
Investors
Questions about Spirea
Who invested in Spirea?
Spirea has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Spirea raised?
Spirea has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Spirea last raise money?
Spirea's most recent round on record is a Seed, in Jul 2020.
What does Spirea do?
, operates as a biotechnology company that develops antibody-drug conjugates for cancer treatments.
Where is Spirea headquartered?
Spirea is headquartered in Cambridge, UK.
Which VCs invest in companies like Spirea?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Spirea's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Spirea? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.